Key Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -64.68%
(FY 2022)
- Profit -10.72%
(FY 2022)
- Ebitda -7.97%
(FY 2022)
- Net Worth -17.71%
(FY 2022)
- Total Assets -53.99%
(FY 2022)
About Key Life Sciences
The Corporate was formerly known as Hawk Biopharma Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yogesh Chandra and Satish Kumar serve as directors at the Company.
- CIN/LLPIN
U24239DL2005PTC139816
- Company No.
139816
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2005
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Key Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Kumar  | Director | 17-Jan-2017 | Current |
Yogesh Chandra  | Director | 17-Mar-2015 | Current |
Financial Performance of Key Life Sciences.
Key Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 64.68% decrease. The company also saw a substantial fall in profitability, with a 10.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Key Life Sciences?
In 2021, Key Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Key Life Sciences?
Unlock and access historical data on people associated with Key Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Key Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Key Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
